Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Texas Scottish Rite Hospital for Children
Study ID
NCT02040714
Status
Enrolling By Invitation

Conditions

  • Legg Calve Perthes Disease

Eligibility Criteria

Sex
ALL
Age
1 Year - 18 Years
Healthy Volunteers
Not accepted

Interventions

  • Osteotomy + Long Term Non-Weight Bearing — PROCEDURE
    Surgical procedure that improves femoral head containment, plus a post-operative protocol that requires patient to maintain non-weight bearing for 6 months.
  • Osteotomy + Short Term Non-Weight Bearing — PROCEDURE
    Surgical procedure that improves femoral head containment, plus a post-operative protocol that allows early return to function after 6 weeks of non-weight bearing.
  • Nonoperative Observation — PROCEDURE
    Group will not undergo any surgical or invasive procedures during course of treatment.
  • Multiple Epiphyseal Drilling — PROCEDURE
    Multiple epiphyseal drilling is a procedure that creates small holes in the femoral head growth plate to increase blood flow into the femoral head.

Study Details

Legg-Calvé-Perthes disease is a childhood hip disorder which is common enough to be a significant public health problem (affects 1 in 740 boys between ages 0-14), but uncommon enough to have a sufficient number of patients from a single institution to perform a definitive prospective study comparing the results of current treatments. The present study will establish a database of prospectively identified patients with Legg-Calvé-Perthes (LCP) Disease and collect information regarding their presentation, treatment, and outcomes in the course of receiving currently available treatments. This study seeks to compare the outcomes of current treatments in the management of different age groups (ages 1-6, 6-8, 8-11, \>11) of patients with Perthes disease at two- and five-year followup and at skeletal maturity. For each age group, two to three common treatment regimens currently used by practicing pediatric orthopaedic surgeons will be compared. The intervention a patient receives is determined through physician treatment expertise, and is not pre-determined by the study.

Key Dates

Start date
Aug 31, 2012
Status verified
May 2025
Primary completion
Sep 30, 2032
Completion
Sep 30, 2032

Study Design

Enrollment
1,500 participants (estimated)

Arms

  • Arm: Nonoperative management between ages 6-8 in early stage
    The choice of non-osteotomy management without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).
  • Arm: Operative management between age 6-8 in early stage
    Operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty) rendered in the early stage of the disease process
  • Arm: Nonoperative management between age 8-11 in early stage
    Patients who do not undergo some form of containment surgery because of medical, social, or other reasons will receive no surgical treatment.
  • Arm: Operative containment with short-term non-weightbearing in early stage
    As per the current standard practice for patients between age 8-11 in developed countries, all patients will undergo some form of containment surgery (pelvic or femoral osteotomy) in order to better "contain" the femoral head underneath the acetabulum. Post-operative treatment will include 6 weeks of non-weight bearing on the operated leg.
  • Arm: Operative containment with prolonged non-weightbearing in early stage
    As per the current standard practice for patients between age 8-11, all patients will undergo some form of containment surgery (pelvic or femoral osteotomy) in order to better "contain" the femoral head underneath the acetabulum. Post-operative treatment will include 6 months of non-weight bearing on the operated leg.
  • Arm: Operative containment for over 11 age group
    Patients presenting over age 11 may receive multiple drilling and be non weight bearing for up to 6 months according to the treating physician's preference. Patients with application of fixator (arthrodiastasis) will be studied in this cohort arm as well, which typically involved 3-4 months followed by 8-12 weeks of non-weight bearing after fixator removal. Other surgical techniques may be included, however these are the most common for this age group.
  • Arm: Nonoperative management in over 11 age group
    Patients will be non-weight bearing and receive physical therapy according to the physician preferences.
  • Arm: Nonoperative management in 1-6 age group
    The choice of non-osteotomy management without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).
  • Arm: Operative management in 1-6 age group
    The choice of osteotomy management with containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).
  • Arm: Late Stage Bracing group
    Patients presenting with \<= 20 degrees of abduction on a maximum abduction x-ray treated with bracing who also present in the late stages of the disease (Waldenstrom Stage IIb or IIIa).The choice of management with or without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).
  • Arm: Late Stage Symptomatic treatment group
    Patients presenting in the late stages of the disease (defined as Waldenstrom stage IIb or IIIa) who are treated symptomatically. The choice of management with or without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).
  • Arm: Late Stage Surgical Containment group
    Patients presenting in the late stages of the disease (defined as Waldenstrom stage IIb or IIIa) who are treated with surgical containment. The choice of management with or without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).

Primary Outcome Measure

Sphericity deviation score of the femoral head [ Time Frame: 5 years post intervention ]

Locations (28)

FacilityCityStateZIPSite coordinators
Children's Hospital of AlabamaBirminghamAlabama35294-
Children's Hospital of Los AngelesLos AngelesCalifornia90027-
Kaiser Permanente HospitalLos AngelesCalifornia90027-
Rady Children's Hospital CaliforniaSan DiegoCalifornia92024-
UCSF Benioff Children's HospitalsSan FranciscoCalifornia94158-
Children's Hospital ColoradoAuroraColorado80045-
Connecticut Children's Medical CenterHartfordConnecticut06106-
Alfred I. DuPont Hospital for Children of the Nemours FoundationWilmingtonDelaware19803-
Children's National Medical CenterWashington D.C.District of Columbia20010-
Children's Orthopaedics of AtlantaAtlantaGeorgia30342-
Ann & Robert H. Lurie Children's Hospital of ChicagoChicagoIllinois60611-
Johns HopkinsBaltimoreMaryland21218-
Children's Hospital BostonBostonMassachusetts02115-5724-
Mayo ClinicRochesterMinnesota55905-
Gillette Children's Specialty HealthcareSaint PaulMinnesota55101-
New York Presbyterian Hospital (Columbia Campus)New YorkNew York10032-
NYU Langone/Hospital for Joint DiseaseNew YorkNew York10003-
Children's Hospital at MontefioreThe BronxNew York10467-
OrthoCarolinaCharlotteNorth Carolina28207-
Cincinnati Children's Hospital Medical CenterCincinnatiOhio45229-
Nationwide Children's HospitalColumbusOhio43205-
Oklahoma University Health Science CenterOklahoma CityOklahoma73104-
Oregon Health and Science UniversityPortlandOregon97239-
Children's Hospital of PhiladelphiaPhiladelphiaPennsylvania19104-
University of Tennessee-Campbell ClinicGermantownTennessee38138-
Texas Scottish Rite Hospital for ChildrenDallasTexas75219-
Texas Children's HospitalHoustonTexas77030-
Seattle Children's HospitalSeattleWashington98105-

Find similar trials in Birmingham, AL